38 filings
8-K
QTTB
Q32 Bio Inc.
26 Mar 24
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
9:57pm
8-K/A
QTTB
Q32 Bio Inc.
22 Mar 24
Other Events
10:23am
8-K
QTTB
Q32 Bio Inc.
20 Mar 24
Other Events
4:06pm
8-K
QTTB
Q32 Bio Inc.
15 Mar 24
Submission of Matters to a Vote of Security Holders
5:18pm
8-K
QTTB
Q32 Bio Inc.
11 Mar 24
Other Events
7:32am
8-K
40snwlin2more87
26 Jan 24
Regulation FD Disclosure
4:13pm
8-K
lyb64i4xrz9vzg 6g3q3
3 Jan 24
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
4:26pm
8-K
nbh0row op
16 Nov 23
Entry into a Material Definitive Agreement
7:45am
8-K
c48aog9
16 Nov 23
Q32 Bio and Homology Medicines Announce Merger Agreement
7:16am
8-K
hsplr
10 Oct 23
Regulation FD Disclosure
5:22pm
8-K
ap61r4pm
27 Jul 23
Cost Associated with Exit or Disposal Activities
5:29pm
8-K
tcczmyb cc2fj4
14 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
53t12mz9
4 Jan 23
Regulation FD Disclosure
5:07pm
8-K
pv6dn
8 Sep 22
Departure of Directors or Certain Officers
4:03pm
8-K
4368ivmi0 ak
16 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
1jbevkj5hikt6qpik
13 Jun 22
Other Events
8:20am
8-K
pmfzk0wdl4c6lp0cvl
21 Apr 22
Departure of Directors or Certain Officers
5:20pm
8-K
7rthk
16 Mar 22
Entry into a Material Definitive Agreement
4:06pm
8-K
4808qc03 ym1w2b93
18 Feb 22
Homology Medicines Provides an Update on pheNIX Gene Therapy Trial for Adults with PKU
12:00am
8-K
d1uj4 9q49
3 Feb 22
Entry into a Material Definitive Agreement
12:00am